Tompkins Financial Corporation (TMP)
Live price chart, market sentiment, and community perspectives for Tompkins Financial Corporation (AMEX: TMP).
Live price chart, market sentiment, and community perspectives for Tompkins Financial Corporation (AMEX: TMP).
On our desk, we are seeing TMP trade up toward a new 52-week high of $102.15 following a record second quarter. Even with diluted EPS up 36% year-over-year to $2.04 and an expanding net interest margin hitting 3.58%, the forward P/E of 12.5 makes it difficult to justify aggressive new buying. The recent $2.8 million insider sale captured on Form 4 also tempers our near-term enthusiasm. We remain neutral, keeping a close eye on whether credit quality metrics stabilize before adjusting our positioning.
Looking at the fundamental credit and liquidity profile, Tompkins Financial is displaying solid underlying strength with Tier 1 capital to average assets climbing to 10.69% and $1.7 billion in available liquidity. However, the bear case centers around elevated non-performing loan ratios and the lingering impact of credit quality metrics. While net charge-offs look better year-over-year due to the absence of last year's large commercial real estate write-down, the overall credit environment requires caution, especially with a Hold consensus from major research providers.
When analyzing regional banking models like Tompkins, evaluating deposit stability and loan growth is crucial. TMP reported period-end loans up 6.9% and average deposits up 4.4% year-over-year despite typical seasonal municipal outflows. The net interest income reached $74.0 million, up 23% from a year ago. Noninterest income took a hit, declining 41.7% down to $13.1 million following the late 2025 insurance business sale. Analysts must factor in these structural revenue shifts when underwriting the bank's core earnings power moving forward.
Watching the market reaction to the latest capital moves, the 4.5% dividend increase to $0.70 per share alongside a completed share repurchase tranche shows management's commitment to returning capital. Firms like KBW have raised targets up to $105 with an outperform view, while others like Piper Sandler sit neutral at $104. This split among sell-side targets underscores the tension between strong operational execution and a valuation that isn't quite cheap enough for an immediate upgrade.
From a risk management standpoint, we are monitoring the omni-bus shelf registration for common and preferred stock filed alongside their strong Q2 results. While it signals financial flexibility for future capital maneuvers, it also introduces potential equity dilution overhang. Combined with elevated asset ratios and recent insider distribution, risk managers should maintain strict stop-loss parameters if holding positions near these 52-week highs.
Explore plasma cleansing, somatic organ swaps, and BCI.